These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 8209383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE, Wagner JG, White SM, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jun 01; 109(1):41-50. PubMed ID: 2038748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE, Emeis JJ, Roth RA.
    Biochem Pharmacol; 1996 Jan 26; 51(2):187-91. PubMed ID: 8615888
    [Abstract] [Full Text] [Related]

  • 8. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan 26; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH, Johnson K, Carpenter LJ, Roth RA.
    J Toxicol Environ Health; 1987 Jan 26; 21(1-2):205-17. PubMed ID: 3573071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
    Taylor DW, Wilson DW, Lamé MW, Dunston SD, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1997 Mar 26; 143(1):196-204. PubMed ID: 9073608
    [Abstract] [Full Text] [Related]

  • 12. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE, Sprugel KH, Hadley KB, Roth RA.
    J Pharmacol Exp Ther; 1986 Apr 26; 237(1):226-31. PubMed ID: 2937908
    [Abstract] [Full Text] [Related]

  • 13. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB, Roth RA.
    Toxicol Pathol; 1997 Apr 26; 25(4):372-80. PubMed ID: 9280120
    [Abstract] [Full Text] [Related]

  • 14. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
    Lappin PB, Ross KL, King LE, Fraker PJ, Roth RA.
    Toxicol Appl Pharmacol; 1998 May 26; 150(1):37-48. PubMed ID: 9630451
    [Abstract] [Full Text] [Related]

  • 15. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA.
    Toxicol Appl Pharmacol; 1990 Nov 26; 106(2):179-200. PubMed ID: 2256110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1989 Jun 15; 99(2):302-13. PubMed ID: 2734793
    [Abstract] [Full Text] [Related]

  • 18. The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter.
    Kodavanti UP, Schladweiler MC, Ledbetter AD, Watkinson WP, Campen MJ, Winsett DW, Richards JR, Crissman KM, Hatch GE, Costa DL.
    Toxicol Appl Pharmacol; 2000 May 01; 164(3):250-63. PubMed ID: 10799335
    [Abstract] [Full Text] [Related]

  • 19. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
    Hilliker KS, Roth RA.
    Exp Lung Res; 1985 May 01; 8(4):201-12. PubMed ID: 4043006
    [Abstract] [Full Text] [Related]

  • 20. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun 01; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.